Evaluation of MLPA for the detection of cryptic subtelomeric rearrangements.
Chromosomal rearrangements involving the telomeres are implied as a significant cause of idiopathic mental retardation. The most frequently used technique to detect these rearrangements was fluorescent in situ hybridization (FISH), an expensive and labor-intensive technique. One of the most promising alternative techniques is multiplex ligation-dependent probe amplification (MLPA). Here, the authors present the evaluation of a double set of probes (the SALSA P036, P019, and P020 human telomere test kits) on a series of 95 patients and 22 normal controls. Overall, 34 patients had been studied by telomeric FISH and MLPA, which was demonstrated to be a reliable method to detect essentially all subtelomeric rearrangements characterized by FISH. In addition, in these 34 patients, 13 dose imbalances were detected by MLPA, but not by FISH analysis. Overall, 12 alterations were observed only with one of the two sets, and they corresponded to polymorphic variants, as they were inherited from healthy parents or also appear in normal controls. The remaining 61 patients were initially studied with SALSA P036, and any putative dose alteration was confirmed with the two other kits and FISH. In the whole series, the authors found 9 dose imbalances evidenced with 2 MLPA kits and confirmed by FISH, representing 10% of patients with subtelomeric rearrangements. On the other hand, one small duplication at 14q11 may be clinically relevant as it appears de novo in one patient. In conclusion, MLPA can be considered a quick, sensitive, cost-effective, and easy method to screen for subtelomeric rearrangements, but any finding based in the testing of one probe should be confirmed by other sources.
Monfort
Sandra
S
Unidad de Genética y Diagnóstico Prenatal, Hospital Universitario La Fe, Valencia, Spain.
Orellana
Carmen
C
Oltra
Silvestre
S
Roselló
Mónica
M
Guitart
Miriam
M
Martínez
Francisco
F
D002872:Chromosome Deletion; D015342:DNA Probes / Q000235:genetics; D005260:Female; D018628:Gene Dosage; D020440:Gene Duplication; D015321:Gene Rearrangement; D005820:Genetic Testing / Q000379:methods* / Q000592:standards; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008607:Intellectual Disability / Q000175:diagnosis* / Q000235:genetics*; D008297:Male; D021141:Nucleic Acid Amplification Techniques / Q000379:methods* / Q000592:standards; D015203:Reproducibility of Results; D016615:Telomere / Q000235:genetics*; D014178:Translocation, Genetic
D015342:DNA Probes